Straumann Group acquired a minority stake in dental software company Carestack Dental Management during the first quarter of 2022. Straumann Group owns several dental brands, including ClearCorrect, 3Shape and Neodent. Carestack provides cloud-based software solutions for dental practices. The acquisition, included in Straumann's April 28 first quarter financial report, expands the company's portfolio to include dental software for dental practices and DSOs. Featured Webinars

Straumann Group acquires minority stake in Carestack

Straumann Group reports very strong first quarter
Ansprechpartner:in Frau                                                                                                                    Silvia                                                        Dobry +41 61 965 15 62
Strong organic double-digit growth in all regions; LATAM fastest-growing
Launch of two innovative challenger brand implants, Neodent Zi and Anthogyr X3
Acquisition of a strategic minority stake in CareStack, a cloud-based practice management software
Outlook for 2022 confirmed: Organic revenue growth expected in the low double-digit percentage range and profitability is expected around 26% including major growth investments
Straumann Group made a strong start to 2022. Revenue in the first quarter reached CHF 589 million and organic growth was 27.2% compared to the same quarter in 2021, which did not see a negative effect due to the pandemic. Revenue in Swiss francs was slightly impacted by a negative currency development mainly related to the Euro. Overall patient flow remained strong in most countries except for some local Covid-19 lockdowns which interrupted the patient flow, notably in China. All regions reported very strong performance in the first quarter. This record result was driven by strong gains supported by the recently launched immediacy implant solutions, which also supported customer conversion in some cases. Other highlights are the continued healthy growth of DrSmile in Europe and the digital solutions portfolio which showed excellent results led by the intraoral scanner segment, the biggest part of this business. Guillaume Daniellot, Chief Executive Officer, said: “I would like to thank every member of our global team for this strong start to the year. This quarter we focused heavily on execution. We started the implementation of several culture programs throughout the company, executed the recent launches the teams are introducing flawlessly and benefited from our implant portfolio catering to all price points. Digital Solutions, led by intraoral scanners, performed very well. Overall, we are constantly working on building our strategic priorities to ensure our long-term success. With this in mind, we are confirming our full year guidance despite the uncertainties around potential geopolitical impacts and COVID-19.”
REGIONAL PERFORMANCES
Strong demand in Europe, Middle East and Africa
The Group’s largest region, Europe, the Middle East and Africa, had a strong first quarter, despite a negative currency effect. EMEA grew organically by 33% compared to the first quarter of 2021, accounting for CHF 267 million. This growth was driven by all segments with particularly strong contributions from orthodontics and implants. The Dental Service Organization (DSO) segment enjoyed very strong growth too, as did the Digital Solutions business. Iberia showed highly impressive results, driven by intraoral scanner sales, premium and challenger implants. Germany being the largest country drove revenue in absolute terms, and Turkey and Romania showed very strong growth. North America continues its growth path
In the first quarter of 2022, North America grew organically by 20.7%, while revenue came to CHF 170 million. Both Canada and the US delivered double-digit growth, driven by strong demand across all major franchises. Within premium implants, the BLT, BLX and TLX lines all grew very strongly reflecting the focus on immediacy. In the challenger segment, Neodent performed very well over the quarter, lifted by a strong performance in the DSO segment and the region’s focus on competitive conversions. A strong performance for implants overall also drove our restorative business in abutments and guided surgery. In Digital Solutions, intraoral scanners were a key driver for growth, with a strong first quarter. Asia Pacific growing steadily with some disruptions in China
Asia Pacific enjoyed organic growth of 18.4% and accounted for revenue of CHF 112 million. China remained a large and growing market, however, the growth dynamic was impacted by several local COVID-19 lockdowns, especially in Shanghai. Some impact was also observed from treatments being deferred because of the Chinese volume-based procurement initiative. These impacts were partially compensated by other markets in the region, such as Japan and Australia which have seen strong growth. The recently established subsidiary in Malaysia performed very well and introduced ClearCorrect in the first quarter. The Group also expanded further within India, opening an office near Delhi. Across the region, premium implants and orthodontics contributed strongly to the overall performance. Latin America fastest growing regionThe region grew 48.8% organically and accounted for CHF 39 million in revenue. All segments performed strongly and particularly in digital solutions the Straumann VirtuoVivo intraoral scanner was driving revenue. Orthodontics grew very rapidly over the first quarter throughout the region. In the premium implant segment, BLT implants significantly contributed to the strong results, in turn driving solid performances for abutments and restorative materials. Neodent continued to grow very strongly in the region and the new educational resource, Neodent Campus, was rolled out during the quarter. In both the premium and value implant segment, the Group gained market share throughout the region, thanks to the direct local footprint in several countries in Latin America. With the biggest market Brazil growing robustly, other countries such as Mexico and Argentina grew even faster. STRATEGIC PROGRESS / NEWS HIGHLIGHTS
Challenger brand launches complement immediacy line-up - Neodent Zi and Anthogyr X3 In the first quarter, the Neodent Zi implant has been launched. This apically tapered ceramic implant ensures that there is no contact between metal and the patient’s tissue. It is a solution that enables to treat patients immediately, thanks to the modern naturally tapered Zirconia implant design. The Zi benefits from a highly innovative production, using injection molding that helps to increase productivity and offer a more affordable solution. Another important launch was the Anthogyr Axiom X3 which is a patented, fully tapered implant designed to offer a universal anchorage in all bone densities. It offers a holistic solution while respecting and preserving the bone, the most valuable environment. By end 2022, Axiom X3 should be fully integrated in all digital workflows. New features to treat more complex orthodontics cases and improve customer experience
ClearCorrect fully launched the ClearPilot 3.0 and 3.1 software which include features that support the treatment of more complex malocclusion cases and enhance the customer experience. The new features offer doctors more control to perform individual tooth movement, the ability to visualize overcorrection, and rate and send feedback on the quality of the setup, improving customer experience. To further support the treatment of more complex cases and to cater for the increasing clinician demand, ClearCorrect began the global launch of cutouts for treatment with elastics and new engager sizes to further customize the treatment to each individual patient need. Digital solutions accelerating and limited market release of the P50 3D printer started
The full market release of the relaunched VirtuoVivo in the first quarter has been welcomed by practitioners who find the increased usability and connectivity help improve their workflows. In addition, the Rapid Shape P50 3D printer, a high-volume high-intensity device, had a limited market release during the quarter and will get a full market release later in 2022. Acquisition of stake in CareStack to provide a digital practice management software
Straumann Group acquired a strategic minority stake in software company CareStack. Combining Straumann Group’s clinical solutions with CareStack’s advanced business intelligence and comprehensive practice operations will offer clinicians a seamless, end-to-end treatment management experience. CareStack’s practice management software is suitable for individual practices, groups and DSOs. This partnership will support dental practices in simplifying treatment planning, scheduling, and payment options, thereby helping Straumann Group clients to provide high-quality care in a more efficient way to their patients. Executive Management Board evolving in line with strategy
Sébastien Roche became Straumann Group’s Chief Operating Officer on April 1st. His role encompasses all Straumann Group production sites involved in implants and biomaterials manufacturing. In addition, Jason Forbes took up the position of Chief Consumer Officer on April 19. He will drive the “Build consumer presence” part of Straumann Group’s strategy, taking on responsibility for Dr Smile, Smilink, Nihon Implant, and direct-to-consumer initiatives. AGM approves proposals including new Board member, increased dividend and share split
At the recent AGM, the shareholders of Straumann Holding AG approved all the Board’s proposals. This includes the election of independent Board member Nadia Tarolli Schmidt, as well as the approval of the 2022 cash dividend of CHF 6.75 per share (2021: CHF 5.75), which was paid on April 11, 2022. On April 20, Straumann Group’s shares were split in a 1:10 share split, allowing for a broader base of investors to become shareholders. Sustainability framework in action
To benefit from the knowledge of people most closely connected to Straumann Group, the company set up an internal environmental idea crowdsourcing platform in the first quarter. The goal is to make sure employees can contribute to improving the Group’s environmental footprint. Over 6 weeks employees contributed more than 230 ideas, a high rate of engagement which speaks well for the scheme. These will now be taken forward and assessed by 28 environmental ambassadors, representing each business unit and each region. Straumann Group will set a target date for getting to net-zero carbon emissions. OUTLOOK 2022 (BARRING UNFORESEEN CIRCUMSTANCES)
Straumann Group confirms the full year guidance despite the uncertainties around potential geopolitical impacts and COVID-19. The Group will seek to anticipate and mitigate supply chain disruption, inflationary and geopolitical developments and their potential impacts. With its strategy and high-performing team in place, organic revenue growth is expected in the low double-digit percentage range and profitability is expected around 26%, including major growth investments. Anlagen

Straumann Group reports very strong first quarter

Straumann Group reports very strong first quarter
Search jobs
Straumann Holding AG / Key word(s): Quarter Results/Sustainability
28-Apr-2022 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement. Quarterly revenue of CHF 589 million, 27.2% organic revenue growth on previous year
Strong organic double-digit growth in all regions; LATAM fastest-growing
Launch of two innovative challenger brand implants, Neodent Zi and Anthogyr X3
Acquisition of a strategic minority stake in CareStack, a cloud-based practice management software
Outlook for 2022 confirmed: Organic revenue growth expected in the low double-digit percentage range and profitability is expected around 26% including major growth investments
REVENUE BY REGION
267.2
+33.0
+20.7
+21.6
+48.8
+27.9
 
Basel, April 28, 2022: Straumann Group made a strong start to 2022. Revenue in the first quarter reached CHF 589 million and organic growth was 27.2% compared to the same quarter in 2021, which did not see a negative effect due to the pandemic. Revenue in Swiss francs was slightly impacted by a negative currency development mainly related to the Euro. Overall patient flow remained strong in most countries except for some local Covid-19 lockdowns which interrupted the patient flow, notably in China. All regions reported very strong performance in the first quarter. This record result was driven by strong gains supported by the recently launched immediacy implant solutions, which also supported customer conversion in some cases. Other highlights are the continued healthy growth of DrSmile in Europe and the digital solutions portfolio which showed excellent results led by the intraoral scanner segment, the biggest part of this business. Guillaume Daniellot, Chief Executive Officer, said: 'I would like to thank every member of our global team for this strong start to the year. This quarter we focused heavily on execution. We started the implementation of several culture programs throughout the company, executed the recent launches the teams are introducing flawlessly and benefited from our implant portfolio catering to all price points. Digital Solutions, led by intraoral scanners, performed very well. Overall, we are constantly working on building our strategic priorities to ensure our long-term success. With this in mind, we are confirming our full year guidance despite the uncertainties around potential geopolitical impacts and COVID-19.'  
Strong demand in Europe, Middle East and Africa
The Group's largest region, Europe, the Middle East and Africa, had a strong first quarter, despite a negative currency effect. EMEA grew organically by 33% compared to the first quarter of 2021, accounting for CHF 267 million. This growth was driven by all segments with particularly strong contributions from orthodontics and implants. The Dental Service Organization (DSO) segment enjoyed very strong growth too, as did the Digital Solutions business. Iberia showed highly impressive results, driven by intraoral scanner sales, premium and challenger implants. Germany being the largest country drove revenue in absolute terms, and Turkey and Romania showed very strong growth. North America continues its growth path
In the first quarter of 2022, North America grew organically by 20.7%, while revenue came to CHF 170 million. Both Canada and the US delivered double-digit growth, driven by strong demand across all major franchises. Within premium implants, the BLT, BLX and TLX lines all grew very strongly reflecting the focus on immediacy. In the challenger segment, Neodent performed very well over the quarter, lifted by a strong performance in the DSO segment and the region's focus on competitive conversions. A strong performance for implants overall also drove our restorative business in abutments and guided surgery. In Digital Solutions, intraoral scanners were a key driver for growth, with a strong first quarter. Asia Pacific growing steadily with some disruptions in China
Asia Pacific enjoyed organic growth of 18.4% and accounted for revenue of CHF 112 million. China remained a large and growing market, however, the growth dynamic was impacted by several local COVID-19 lockdowns, especially in Shanghai. Some impact was also observed from treatments being deferred because of the Chinese volume-based procurement initiative. These impacts were partially compensated by other markets in the region, such as Japan and Australia which have seen strong growth. The recently established subsidiary in Malaysia performed very well and introduced ClearCorrect in the first quarter. The Group also expanded further within India, opening an office near Delhi. Across the region, premium implants and orthodontics contributed strongly to the overall performance. Latin America fastest growing regionThe region grew 48.8% organically and accounted for CHF 39 million in revenue. All segments performed strongly and particularly in digital solutions the Straumann VirtuoVivo intraoral scanner was driving revenue. Orthodontics grew very rapidly over the first quarter throughout the region. In the premium implant segment, BLT implants significantly contributed to the strong results, in turn driving solid performances for abutments and restorative materials. Neodent continued to grow very strongly in the region and the new educational resource, Neodent Campus, was rolled out during the quarter. In both the premium and value implant segment, the Group gained market share throughout the region, thanks to the direct local footprint in several countries in Latin America. With the biggest market Brazil growing robustly, other countries such as Mexico and Argentina grew even faster. STRATEGIC PROGRESS / NEWS HIGHLIGHTS
 
Challenger brand launches complement immediacy line-up - Neodent Zi and Anthogyr X3In the first quarter, the Neodent Zi implant has been launched. This apically tapered ceramic implant ensures that there is no contact between metal and the patient's tissue. It is a solution that enables to treat patients immediately, thanks to the modern naturally tapered Zirconia implant design. The Zi benefits from a highly innovative production, using injection molding that helps to increase productivity and offer a more affordable solution. Another important launch was the Anthogyr Axiom X3 which is a patented, fully tapered implant designed to offer a universal anchorage in all bone densities. It offers a holistic solution while respecting and preserving the bone, the most valuable environment. By end 2022, Axiom X3 should be fully integrated in all digital workflows. New features to treat more complex orthodontics cases and improve customer experience
ClearCorrect fully launched the ClearPilot 3.0 and 3.1 software which include features that support the treatment of more complex malocclusion cases and enhance the customer experience. The new features offer doctors more control to perform individual tooth movement, the ability to visualize overcorrection, and rate and send feedback on the quality of the setup, improving customer experience. To further support the treatment of more complex cases and to cater for the increasing clinician demand, ClearCorrect began the global launch of cutouts for treatment with elastics and new engager sizes to further customize the treatment to each individual patient need. Digital solutions accelerating and limited market release of the P50 3D printer started
The full market release of the relaunched VirtuoVivo in the first quarter has been welcomed by practitioners who find the increased usability and connectivity help improve their workflows. In addition, the Rapid Shape P50 3D printer, a high-volume high-intensity device, had a limited market release during the quarter and will get a full market release later in 2022. Acquisition of stake in CareStack to provide a digital practice management software
Straumann Group acquired a strategic minority stake in software company CareStack. Combining Straumann Group's clinical solutions with CareStack's advanced business intelligence and comprehensive practice operations will offer clinicians a seamless, end-to-end treatment management experience. CareStack's practice management software is suitable for individual practices, groups and DSOs. This partnership will support dental practices in simplifying treatment planning, scheduling, and payment options, thereby helping Straumann Group clients to provide high-quality care in a more efficient way to their patients. Executive Management Board evolving in line with strategy
Sébastien Roche became Straumann Group's Chief Operating Officer on April 1st. His role encompasses all Straumann Group production sites involved in implants and biomaterials manufacturing. In addition, Jason Forbes took up the position of Chief Consumer Officer on April 19. He will drive the 'Build consumer presence' part of Straumann Group's strategy, taking on responsibility for Dr Smile, Smilink, Nihon Implant, and direct-to-consumer initiatives. AGM approves proposals including new Board member, increased dividend and share split
At the recent AGM, the shareholders of Straumann Holding AG approved all the Board's proposals. This includes the election of independent Board member Nadia Tarolli Schmidt, as well as the approval of the 2022 cash dividend of CHF 6.75 per share (2021: CHF 5.75), which was paid on April 11, 2022. On April 20, Straumann Group's shares were split in a 1:10 share split, allowing for a broader base of investors to become shareholders. Sustainability framework in action
To benefit from the knowledge of people most closely connected to Straumann Group, the company set up an internal environmental idea crowdsourcing platform in the first quarter. The goal is to make sure employees can contribute to improving the Group's environmental footprint. Over 6 weeks employees contributed more than 230 ideas, a high rate of engagement which speaks well for the scheme. These will now be taken forward and assessed by 28 environmental ambassadors, representing each business unit and each region. Straumann Group will set a target date for getting to net-zero carbon emissions. OUTLOOK 2022 (BARRING UNFORESEEN CIRCUMSTANCES)
Straumann Group confirms the full year guidance despite the uncertainties around potential geopolitical impacts and COVID-19. The Group will seek to anticipate and mitigate supply chain disruption, inflationary and geopolitical developments and their potential impacts. With its strategy and high-performing team in place, organic revenue growth is expected in the low double-digit percentage range and profitability is expected around 26%, including major growth investments. About Straumann Group
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss. Headquartered in Basel, Switzerland, the Group currently employs more than 9000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

Ambition to achieve CHF 5 billion revenue by 2030 considering an average organic growth rate of at least 10%, core EBIT margin expected to range between 25-30% in the next years depending on investment, and on continuous increase of gross dividend
Culture remains a key pillar with an employee engagement score of 80 in 2021 – in the top 25% of companies
Core implantology business strongly positioned to grow from 29% market share across premium and value segments through innovation and geographic expansion respectively
Orthodontics business set to grow via sharpening its value proposition development, expanding geographical presence and driving complementary business models
Digital transformation to shape new pathways for treatment and customer service, to become a digitally-powered oral care company
Dental Service Organizations growing in importance in a consolidating market
New sustainability framework integrated in business strategy, including target of 100% renewable electricity by 2024 and net-zero carbon emissions target to be set in 2022
Today at its Capital Markets Day, Straumann Group will present its evolved strategy to achieve long-term growth. The Group has enjoyed strong growth over the past years, outperforming both competitors and the market. The new strategy lays the foundation to enable the Group to continue this path. Since 2013, when Straumann Group was still an implantology-only business, it has significantly expanded its business scope. Today, the Group operates in a potential CHF 18 billion market covering implantology, CADCAM prosthetics, orthodontics and digital equipment. Straumann’s product mix and sales distribution have diversified greatly since 2013, when EMEA contributed most revenue. Today more than half of the revenue comes from areas outside EMEA, with about a quarter of revenue coming from the LATAM and APAC regions. This share is expected to further develop due to the ongoing strategic geographic expansion in all business areas. Straumann Group CEO Guillaume Daniellot said: “The evolved strategy will ensure we achieve our growth and revenue ambition of CHF 5 billion and impact 10 million smiles by 2030. It captures three major shifts. We will evolve from being product-centric to customer-centric in everything we do, shift from being a total solution provider for esthetic dentistry to a digitally-powered oral care company, and lastly move from a single to multiple business model company to address different stakeholders including health consumers. We will focus on culture, digital transformation and sustainability to enable the four strategic priorities of maintaining implant leadership, becoming a leader in orthodontics, winning strategic target groups and building consumer presence.”
High-performance culture to accelerate Straumann’s growth and help realize ambitious targets
The Group’s strong focus on customers and patients means continued investment in innovation and services. The Group is continuously building its cultural journey to support future growth. This sharp emphasis on culture resulted in a Group-wide employee engagement score of 80 in 2021 – a score which places the Group in the top 25% of companies worldwide. Drive digital transformation
Digital disruption is everywhere, and it’s been accelerated by COVID-19. In the dental industry, digital technologies are transforming patient communication, practice management, diagnostics, and of course the treatments themselves. Widening digital innovation means quicker, more efficient treatments as well as better outcomes – benefitting dentists, technicians and patients. When it comes to tooth replacement and teeth straightening, Straumann Group is making strong inroads in digitizing treatment workflows. The Group’s active markets include CADCAM equipment as well as consumables and services, with the strategy to make use of open systems and connectivity instead of closed platforms. A key pillar of the Group’s digital transformation strategy, to strengthen customer loyalty and deliver frictionless customer experiences, will be to provide a convenient single digital platform for all solutions of the Group and its partners. Expand implant market leadership
Dental implants remain at the core of the Group’s business with an overall market share of 29% in a global market of CHF 5.2 billion. This means that more than one in every four dental implants that are placed in the world are Straumann Group implants. The multiple-brand strategy enables a presence at all different price points offering solutions in the premium and value segments. Innovation remains a strong driver for premium, in particular in the immediacy apically and fully tapered segments. Geographical expansion will be the most important growth driver in the value segment. In both segments, education is a key driver for expanding access to professionals and ultimately healthcare consumers. Become a leading orthodontic franchise
The Group started to establish its orthodontic business in 2017 with the acquisition of the US company ClearCorrect. Since then there have been significant investments in further strengthening the offering from product and digital portfolio standpoints as well as from a fast service perspective and international expansion. With a potential global market of CHF 5.3 billion and the Group having a low single-digit market share, the upside potential is high. By widening the offering to additional customer segments and health consumers, exploring new business models as well as expanding the geographic footprint, the ClearCorrect business is very well positioned for future growth. Straumann’s orthodontic presence has grown from 13 markets in 2017 to 46 markets in 2021. Win strategic target groups
Consolidation is a key trend in oral healthcare which will lead to fewer single, independent practices. Dental Service Organizations (DSO) are on the rise, particularly in North America, Europe and China. In 2015, ∼7% of implants placed were placed by practitioners who were part of a DSO, increasing to ∼15% in the 6 years to 2021. By 2025, it is estimated* that around ∼30% of implants in major markets will be placed by practitioners who are part of DSOs. Implants, clear aligners and esthetics are key growth drivers for this important customer group. Straumann Group’s palette of services can be tailored to support each DSO. This includes orthodontics and implantology, but also digital solutions, customer success management, strategic account development, as well as training and education. Build direct to consumer presence
Health consumers are educating themselves, demanding more and taking ownership of healthcare decisions. Digital touchpoints and the patient experience throughout the treatment journey are becoming increasingly important. In the clear aligner market, advancements in digital smile simulations, treatment planning and teledentistry solutions make awareness and access to treatment easier, more convenient and have given rise to direct-to-consumer activities. To address this trend, the Group started to build direct-to-consumer presence through the acquisitions of DrSmile in 2020 and Smilink in 2021. To develop this strategic priority, the Group is in the process of recruiting a Chief Consumer Officer. New Sustainability Framework
The Group brings lasting improvements to people’s lives, and its success is built upon acting sustainably to improve the quality of life today and for future generations. Straumann Group CFO Peter Hackel said: “Rooted in the company’s heritage of creating long-term value for all stakeholders in a responsible manner, the new Sustainability Framework is a strategic business priority. The Group aspires to become a role model in its industry.”
The Sustainability Framework is based on input from interviews with more than 80 internal and external stakeholders. It is built upon the commitment to advancing oral care, empowering people, caring for the planet and society, and acting with responsibility to deliver on our purpose ‘to unlock the potential of people’s lives’. The major targets include: impacting 10 million smiles by 2030, maintaining 35% of educational activities in low- and middle-income countries, having gender parity in leadership positions by 2026, 100% renewable electricity by 2024 and a net zero carbon emissions target will be set in 2022. Growth ambition (Barring unforeseen circumstance)
Considering the Group’s significant expansion of its business and geographical footprint, it is operating in a potential CHF 18 billion market. In order to achieve the Group’s ambition of CHF 5 billion revenue by 2030, an average organic growth rate of at least 10% annually is needed. The strategy will require continuing investments in growth leading to a core EBIT margin in the range of 25-30% - at constant FX rates - in the next years depending on the size of the investments. In general, the Group will continue to provide guidance on a yearly basis and aims to continuously increase its gross dividend. *Straumann Group estimate
Disclaimer
This release contains forward-looking statements that reflect the current views of management, and which are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expressed or implied in this document. Statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, pandemics, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Straumann’s control. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise. This release constitutes neither an offer to sell nor a solicitation to buy any securities. Website Promotion
Institut Straumann AG
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss. Headquartered in Basel, Switzerland, the Group currently employs more than 8000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners. Das könnte Sie auch interessieren
03.12.2021

Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion

Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
EQS-News: Straumann Holding AG / Key word(s): Strategic Company Decision/Sustainability
16.12.2021 / 07:00
Ambition to achieve CHF 5 billion revenue by 2030 considering an average organic growth rate of at least 10%, core EBIT margin expected to range between 25-30% in the next years depending on investment, and on continuous increase of gross dividend
Culture remains a key pillar with an employee engagement score of 80 in 2021 - in the top 25% of companies
Core implantology business strongly positioned to grow from 29% market share across premium and value segments through innovation and geographic expansion respectively
Orthodontics business set to grow via sharpening its value proposition development, expanding geographical presence and driving complementary business models
Digital transformation to shape new pathways for treatment and customer service, to become a digitally-powered oral care company
Dental Service Organizations growing in importance in a consolidating market
New sustainability framework integrated in business strategy, including target of 100% renewable electricity by 2024 and net-zero carbon emissions target to be set in 2022
Basel, December 16, 2021: Today at its Capital Markets Day, Straumann Group will present its evolved strategy to achieve long-term growth. The Group has enjoyed strong growth over the past years, outperforming both competitors and the market. The new strategy lays the foundation to enable the Group to continue this path. Since 2013, when Straumann Group was still an implantology-only business, it has significantly expanded its business scope. Today, the Group operates in a potential CHF 18 billion market covering implantology, CADCAM prosthetics, orthodontics and digital equipment. Straumann's product mix and sales distribution have diversified greatly since 2013, when EMEA contributed most revenue. Today more than half of the revenue comes from areas outside EMEA, with about a quarter of revenue coming from the LATAM and APAC regions. This share is expected to further develop due to the ongoing strategic geographic expansion in all business areas. Straumann Group CEO Guillaume Daniellot said: 'The evolved strategy will ensure we achieve our growth and revenue ambition of CHF 5 billion and impact 10 million smiles by 2030. It captures three major shifts. We will evolve from being product-centric to customer-centric in everything we do, shift from being a total solution provider for esthetic dentistry to a digitally-powered oral care company, and lastly move from a single to multiple business model company to address different stakeholders including health consumers. We will focus on culture, digital transformation and sustainability to enable the four strategic priorities of maintaining implant leadership, becoming a leader in orthodontics, winning strategic target groups and building consumer presence.'  
High-performance culture to accelerate Straumann's growth and help realize ambitious targets
The Group's strong focus on customers and patients means continued investment in innovation and services. The Group is continuously building its cultural journey to support future growth. This sharp emphasis on culture resulted in a Group-wide employee engagement score of 80 in 2021 - a score which places the Group in the top 25% of companies worldwide. Drive digital transformation
Digital disruption is everywhere, and it's been accelerated by COVID-19. In the dental industry, digital technologies are transforming patient communication, practice management, diagnostics, and of course the treatments themselves. Widening digital innovation means quicker, more efficient treatments as well as better outcomes - benefitting dentists, technicians and patients. When it comes to tooth replacement and teeth straightening, Straumann Group is making strong inroads in digitizing treatment workflows. The Group's active markets include CADCAM equipment as well as consumables and services, with the strategy to make use of open systems and connectivity instead of closed platforms. A key pillar of the Group's digital transformation strategy, to strengthen customer loyalty and deliver frictionless customer experiences, will be to provide a convenient single digital platform for all solutions of the Group and its partners. Expand implant market leadership
Dental implants remain at the core of the Group's business with an overall market share of 29% in a global market of CHF 5.2 billion. This means that more than one in every four dental implants that are placed in the world are Straumann Group implants. The multiple-brand strategy enables a presence at all different price points offering solutions in the premium and value segments. Innovation remains a strong driver for premium, in particular in the immediacy apically and fully tapered segments. Geographical expansion will be the most important growth driver in the value segment. In both segments, education is a key driver for expanding access to professionals and ultimately healthcare consumers. Become a leading orthodontic franchise
The Group started to establish its orthodontic business in 2017 with the acquisition of the US company ClearCorrect. Since then there have been significant investments in further strengthening the offering from product and digital portfolio standpoints as well as from a fast service perspective and international expansion. With a potential global market of CHF 5.3 billion and the Group having a low single-digit market share, the upside potential is high. By widening the offering to additional customer segments and health consumers, exploring new business models as well as expanding the geographic footprint, the ClearCorrect business is very well positioned for future growth. Straumann's orthodontic presence has grown from 13 markets in 2017 to 46 markets in 2021. Win strategic target groups
Consolidation is a key trend in oral healthcare which will lead to fewer single, independent practices. Dental Service Organizations (DSO) are on the rise, particularly in North America, Europe and China. In 2015, ∼7% of implants placed were placed by practitioners who were part of a DSO, increasing to ∼15% in the 6 years to 2021. By 2025, it is estimated* that around ∼30% of implants in major markets will be placed by practitioners who are part of DSOs. Implants, clear aligners and esthetics are key growth drivers for this important customer group. Straumann Group's palette of services can be tailored to support each DSO. This includes orthodontics and implantology, but also digital solutions, customer success management, strategic account development, as well as training and education. Build direct to consumer presence
Health consumers are educating themselves, demanding more and taking ownership of healthcare decisions. Digital touchpoints and the patient experience throughout the treatment journey are becoming increasingly important. In the clear aligner market, advancements in digital smile simulations, treatment planning and teledentistry solutions make awareness and access to treatment easier, more convenient and have given rise to direct-to-consumer activities. To address this trend, the Group started to build direct-to-consumer presence through the acquisitions of DrSmile in 2020 and Smilink in 2021. To develop this strategic priority, the Group is in the process of recruiting a Chief Consumer Officer. New Sustainability Framework
The Group brings lasting improvements to people's lives, and its success is built upon acting sustainably to improve the quality of life today and for future generations. Straumann Group CFO Peter Hackel said: 'Rooted in the company's heritage of creating long-term value for all stakeholders in a responsible manner, the new Sustainability Framework is a strategic business priority. The Group aspires to become a role model in its industry.'  
The Sustainability Framework is based on input from interviews with more than 80 internal and external stakeholders. It is built upon the commitment to advancing oral care, empowering people, caring for the planet and society, and acting with responsibility to deliver on our purpose 'to unlock the potential of people's lives'. The major targets include: impacting 10 million smiles by 2030, maintaining 35% of educational activities in low- and middle-income countries, having gender parity in leadership positions by 2026, 100% renewable electricity by 2024 and a net zero carbon emissions target will be set in 2022. Growth ambition (Barring unforeseen circumstance)
Considering the Group's significant expansion of its business and geographical footprint, it is operating in a potential CHF 18 billion market. In order to achieve the Group's ambition of CHF 5 billion revenue by 2030, an average organic growth rate of at least 10% annually is needed. The strategy will require continuing investments in growth leading to a core EBIT margin in the range of 25-30% - at constant FX rates - in the next years depending on the size of the investments. In general, the Group will continue to provide guidance on a yearly basis and aims to continuously increase its gross dividend. About Straumann Group
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss. Headquartered in Basel, Switzerland, the Group currently employs more than 8000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

CareCredit, from Synchrony Financial, is a health, wellness, and personal care credit card accepted through a national network of healthcare providers and health-focused retailers.

CareCredit

ClearCorrect has partnered with CareCredit to offer promotional financing on ClearCorrect Cases .

ClearCorrect Partners with CareCredit to Offer Promotional Financing on Aligner Cases

Dental Monitoring allows orthodontists and dentists to remotely follow the treatment of their patients. After downloading the DM app to their smartphones, patients follow the patented DM auto-scan procedure. DM AI technology then extracts from these scans the essential parameters desired by the practitioner and combines them with the 3D dental modelings captured at the beginning of treatment.

Dental Monitoring

BSI Group, aka British Standards Institution, is a multinational business services provider that helps clients drive performance, manage risk, and grow sustainably through the adoption of international management systems standards. BSI's influence spans multiple sectors with a particular focus on Aerospace, Automotive, Built Environment, Food, Healthcare, and IT.

British Standards Institution

ClearCorrect

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Companies delivering dental care products and services. Excludes practice networks.

Dental Health

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Medical Devices

Health IT 

Acquired

ClearCorrect makes clear orthodontic corrective devices that straighten teeth without the need for braces.

First funding	8/17/2017
Last Funding	8/17/2017
Investor	Straumann
Rounds	1 Acquired
Board Seats
Type	Corporation
Location	Switzerland

Wells Fargo Success Story

3M Success Story

Platform Overview

ClearCorrect

Investors Count

Deal Terms

ClearCorrect Funding, ClearCorrect Valuation & ClearCorrect Revenue

ClearCorrect Deal Terms

1 Deal Term

ClearCorrect Investors

Discover the right solution for your team

Date	8/17/2017
Round	Acquired
Amount
Investors	Straumann
Valuation	$99M
Revenue	0 FY undefined
Sources	2